ASX:BGT Bio-Gene Technology (BGT) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Bio-Gene Technology Stock (ASX:BGT) 30 days 90 days 365 days Advanced Chart Get Bio-Gene Technology alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationA$7.45 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University to refine the process for oil extraction; and with BASF, Grains Research and Development Corporation, and Queensland Department of Agriculture and Fisheries for testing of Flavocide in grain storage. Bio-Gene Technology Limited was incorporated in 1995 and is based in Melbourne, Australia. Read More Receive BGT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bio-Gene Technology and its competitors with MarketBeat's FREE daily newsletter. Email Address BGT Stock News HeadlinesBio-Gene Technology Raises $2.45 Million Through Share Purchase PlanJune 1, 2025 | tipranks.comPositive Signs As Multiple Insiders Buy Bio-Gene Technology StockMay 15, 2025 | finance.yahoo.comSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. | Stansberry Research (Ad)Bio-Gene Technology Showcases Innovations at NWR Virtual Healthcare Conference 2025March 19, 2025 | tipranks.comBio-Gene Technology to Present at NWR Virtual Healthcare ConferenceMarch 16, 2025 | tipranks.comBio-Gene Technology And 2 Other ASX Penny Stocks To Watch For GrowthJanuary 30, 2025 | uk.finance.yahoo.comGuess which ASX small-cap stock exploded 154% on big US news!January 29, 2025 | msn.comBio-Gene jumps sharply as US DoD awards grants for novel insecticide developmentJanuary 29, 2025 | msn.comSee More Headlines BGT Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Bio-Gene Technology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bio-Gene Technology investors own include Revvity (PKI), Gray Media (GTN), (NESCQ) (NESCQ), Teradyne (TER), AbbVie (ABBV), Aphria (APHA) and AquaBounty Technologies (AQB). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryFinancial Services Current SymbolASX:BGT CIKN/A Webwww.bio-gene.com.au Phone61 3 9628 4178FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$2.41 million Net Margins-13,150.54% Pretax MarginN/A Return on Equity-74.33% Return on Assets-44.61% Debt Debt-to-Equity RatioN/A Current Ratio8.49 Quick Ratio6.72 Sales & Book Value Annual SalesA$445.73 thousand Price / Sales0.00 Cash FlowN/A Price / Cash Flow7.04 Book ValueA$0.01 per share Price / BookN/AMiscellaneous Outstanding Shares201,360,000Free FloatN/AMarket CapA$7.45 million OptionableNot Optionable Beta0.73 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free Report This page (ASX:BGT) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.The robotics revolution is here. And it's set to impact everything from how we manufacture goods to how we ...Weiss Ratings | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Gene Technology Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Gene Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
